The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 15%.
GAMCO Global Gold Natural Resources & Income Trust
GGN · NYSE AMERICAN · USD · Market cap $773M
GAMCO Global Gold, Natural Resources & Income Trust is a closed ended equity mutual fund launched by GAMCO Investors, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-06-14
Screened 2026-06-14 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
GAMCO Global Gold Natural Resources & Income Trust holds its Accumulation at $4.95. Consolidating, no directional conviction, held for 86 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 86 days |
| Price at the screen | $4.95 |
| Valuation | 2.46 trailing · N/A forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.29 |
Five Screens, Shown in Full
Does not pass. Financial sector: Financial
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Financial sector: Financial | Fail |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | Excluded | Below 5% | of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Business, in Plain Words| Trailing P/E | 2.5xvery cheap relative to earnings |
| EPS, trailing | 2.01 |
| Revenue growth | +12.0%steady growth |
| Profit margin | 1,371.1%highly profitable on every dollar of sales |
| Return on equity | 39.0%an exceptional return on shareholder capital |
| Dividend yield | 727.00% |
| Debt to equity | 2.10heavy leverage: higher risk if revenue softens |
| Beta | 0.29barely tracks the market's swings |
| 52-week range | 4.31 - 5.88 |
| Moat | NONE |
| Market cap | $773M |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGGN trades on NYSE AMERICAN. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 15%.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 16%. Our forward projection puts the odds of a 10% gain over the next month near 15%.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $5.40 | -11.6% | $0.03 | $890 | -11.0% |
| 2 months | $5.45 | -12.4% | $0.06 | $887 | -11.3% |
| 3 months | $5.39 | -11.4% | $0.09 | $903 | -9.7% |
| 6 months | $5.05 | -5.4% | $0.18 | $981 | -1.9% |
| 1 year | $4.12 | +16.0% | $0.36 | $1,247 | +24.7% |
| 2 years | $3.46 | +38.0% | $0.72 | $1,588 | +58.8% |
| 3 years | $2.93 | +63.0% | $1.08 | $1,998 | +99.8% |
| 5 years | $2.67 | +78.9% | $1.80 | $2,464 | +146.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GGN does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.